Concepedia

Ken Dellamaggiore

KD

4

Publications

444

Citations

4

H-Index

2014

Active since

Affiliations

Amgen (United States)(Current)

Ken Dellamaggiore is an author at Amgen (United States) specializing in protein folding, medicine, and tumor biology.

Top concepts

Publications per year

2014–2023

4

Publications

4

A “Click Chemistry Platform” for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation

Ryan P. Wurz, Ken Dellamaggiore, Hannah Dou et al. · Journal of Medicinal Chemistry · 2017 · 196 citations

, , +17

Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability

Paul E. Harrington, Kaustav Biswas, David J. Malwitz et al. · ACS Medicinal Chemistry Letters · 2014 · 103 citations · Full text

, , +20

Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation

Ryan P. Wurz, Huan Rui, Ken Dellamaggiore et al. · Nature Communications · 2023 · 103 citations · Full text

Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases

Xin Luo, Ivonne Archibeque, Ken Dellamaggiore et al. · iScience · 2022 · 42 citations · Full text

, , +17

Rows per page

1–4 of 4